Microglia Activation During Neuroinflammation: Steady-State Microglia
Click on one of the other stages of microglia activation to see the molecules involved in that process. Click on Overview to see the generalized process of microglia activation during neuroinflammation.
EMR1
EMR1
Integrin alpha M
Integrin alpha M
CD64
CD64
Use our Product Suggestion form to enter a request.
You will be notified once it becomes available.
Use our Product Suggestion form to enter a request.
You will be notified once it becomes available.
IGF-I
IGF-I
P2RY12
P2RY12
beta-NGF
NT-3
beta-NGF
NT-3
TrkA
TrkB
TrkC
TrkA
TrkB
TrkC
Non-selective Dopamine Receptor Agonists
Non-selective Dopamine Receptor Antagonists
Non-selective Dopamine Receptor Products
Additional Dopaminergic-related Products
Dopaminergic-related Inhibitors
Caged Compounds
Additional GABA Compounds
Adrenergic Receptor Ligand Sets
Adrenergic Related Compound Inhibitors
All Adrenergic Products
All Noradrenaline Products
VIP
VIP Receptor Agonists
VIP Receptor Antagonists
GABA
Noradrenaline
VIP
GABA
Noradrenaline
VIP
Non-selective Dopamine Receptor Agonists
Non-selective Dopamine Receptor Antagonists
Non-selective Dopamine Receptor Products
Additional Dopaminergic-related Products
Dopaminergic-related Inhibitors
Caged Compounds
Additional GABA Compounds
Adrenergic Receptor Ligand Sets
Adrenergic Related Compound Inhibitors
All Adrenergic Products
All Noradrenaline Products
VIP
VIP Receptor Agonists
VIP Receptor Antagonists
Dopamine D1 and D5 Receptor Agonists
Dopamine D1 and D5 Receptor Antagonists
Dopamine D2 R/DRD2
Dopamine D2 Receptor Agonists
Dopamine D2 Receptor Antagonists
Dopamine D2 Receptor Modulators
Dopamine Receptor Ligands
Non-selective Dopamine Receptor Agonists
Non-selective Dopamine Receptor Antagonists
Non-selective Dopamine Receptor Products
Additional Dopaminergic-related Products
Dopaminergic-related Inhibitors
Caged Compounds
GABA B R1
GABA B R2
GABA B Receptor Agonists
GABA B Receptor Antagonists
GABA B Receptor Modulators
GABA B Receptor Compounds
Additional GABA Compounds
Adrenergic beta-2 Receptor Agonists
Adrenergic beta-2 Receptor Antagonists
Adrenergic beta-2 Receptor Ligand Sets
Adrenergic Receptor Ligand Sets
Adrenergic Related Compound Inhibitors
All Adrenergic Products
All Noradrenaline Products
VIP R1/VPAC1
VIP R2
VIP Receptor Agonists
VIP Receptor Antagonists
DRD2
GABA B Receptor
Adrenergic beta-2 R
VIP R1
VIP R2
DRD2
GABA B Receptor
Adrenergic beta-2 R
VIP R1
VIP R2
Dopamine D1 and D5 Receptor Agonists
Dopamine D1 and D5 Receptor Antagonists
Dopamine D2 R/DRD2
Dopamine D2 Receptor Agonists
Dopamine D2 Receptor Antagonists
Dopamine D2 Receptor Modulators
Dopamine Receptor Ligands
Non-selective Dopamine Receptor Agonists
Non-selective Dopamine Receptor Antagonists
Non-selective Dopamine Receptor Products
Additional Dopaminergic-related Products
Dopaminergic-related Inhibitors
Caged Compounds
GABA B R1
GABA B R2
GABA B Receptor Agonists
GABA B Receptor Antagonists
GABA B Receptor Modulators
GABA B Receptor Compounds
Additional GABA Compounds
Adrenergic beta-2 Receptor Agonists
Adrenergic beta-2 Receptor Antagonists
Adrenergic beta-2 Receptor Ligand Sets
Adrenergic Receptor Ligand Sets
Adrenergic Related Compound Inhibitors
All Adrenergic Products
All Noradrenaline Products
VIP R1/VPAC1
VIP R2
VIP Receptor Agonists
VIP Receptor Antagonists
Fractalkine
Fractalkine
CD172a
CD172a
beta 2
beta 2
Microglia, the immune cells of the nervous system, are typically in a quiescent, or immune-suppressed, state during normal conditions in the brain. During this time, they assume a ramified morphology, which is characterized by a very small cell body with elongated, ramified processes. These ramified microglia contribute to brain homeostasis by supporting myelin turnover, eliminating or remodeling synapses, monitoring neural firing, and actively scavenging the local environment for pathogens or tissue damage. Microglial are maintained in the ramified state through interactions with soluble and membrane-bound factors from neighboring cells. For example, Fractalkine and CD200, found on the cell surface of healthy neurons, interact with their respective receptors on microglia. These microglia receptors contain ITIM (immunoreceptor tyrosine-based inhibitory) motifs in their intracellular domain that, when phosphorylated, suppress downstream immune signaling. Additional ligand-receptor interactions that regulate microglia activation includes CD22, HSP60, and CD47 on neurons binding to CD45, TREM-2, and SIRP alpha, respectively, on microglia. Neurons also release neurotrophic factors, such as BDNF and beta-NGF, that contribute to the immune-suppressed state of microglia by inhibiting the expression of MHC class II and co-stimulatory molecules. In addition, various neurotransmitters and neuropeptides, such as GABA and dopamine, will bind to their respective receptors on microglia and suppress the production of proinflammatory cytokines. Activation of microglia is initiated, in part, following the loss of these inhibitory signals.
To learn more about our products for neuroinflammation, please visit our Neuroinflammation Research Area.